Interleukin-27 augments the inhibitory effects of sorafenib on bladder cancer cells

Both sorafenib and interleukin-27 (IL-27) are antineoplastic drugs. This study aimed to investigate the synergistic effect of these two drugs on bladder cancer cells. HTB-9 and T24 cells were stimulated with IL-27 (50 ng/mL), sorafenib (2 μM) or the synergistic action of these two drugs. The cells w...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, J.Y., Yin, H.S., Li, H.S., Yu, X.Q., Han, X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520222/
https://www.ncbi.nlm.nih.gov/pubmed/28746469
http://dx.doi.org/10.1590/1414-431X20176207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520222/
https://www.ncbi.nlm.nih.gov/pubmed/28746469
http://dx.doi.org/10.1590/1414-431X20176207

Ejemplares similares